Evaluation of immune responses induced by a novel human papillomavirus type 16 E7 peptide-based vaccine with Candida skin test reagent as an adjuvant in C57BL/6 mice.
Evaluation of immune responses induced by a novel human papillomavirus type 16 E7 peptide-based vaccine with Candida skin test reagent as an adjuvant in C57BL/6 mice.
复制标题
新型人乳头瘤病毒 16 型 E7 肽疫苗诱导的免疫反应评估
DOI:
10.1016/j.intimp.2018.01.037
复制
发表时间:
2018-03
影响因子:
5.6
通讯作者:
Wang X
中科院分区:
文献类型:
--
作者:
Wang X;Che Y;Chen B;Zhang Y;Nakagawa M;Wang X
Cell mediated immune (CMI) responses are crucial for the clearance of human papillomavirus (HPV) infection and HPV-associated lesions. Activated CD8 T cells are critical effector cells in recognizing and killing HPV-infected or HPV-transformed cells. CD4 T cells provide help for priming the generation and maintenance of CD8 T cells as well as for tumors immunity. An ideal therapeutic HPV peptide-based vaccines should induce both a robust CD8 T-cell response as well as a CD4 T-cell response for ensuring their efficiency. Candida skin test reagent was demonstrated to be able to induce the secretion of IL-12 by Langerhans cells and T-cell proliferation in vitro by our group, which indicated the potential of Candida to enhance CMI response. In this current study, we designed a novel HPV peptide-based vaccine which includes HPV16 E7 peptides and Candida as an adjuvant. The immune response induced by the vaccine was comprehensively evaluated. The results showed that the vaccine induced significant HPV-specific CD8 T-cell and Th1 CD4 T-cell responses as well as humoral immune response. It is interesting that Candida alone induced significant polarization of Th1 response and the production of IFN-ɣ, which indicated Candida alone may be used as a potential immunotherapeutic reagent not only for HPV-associated lesions but also for other viral infection or even cancers.
登录
查看更多内容
影响因子:
20.3
作者:
Hilkens, CMU;Kalinski, P;Kapsenberg, ML
通讯作者:
Kapsenberg, ML
DOI:
10.1007/s00262-016-1821-x
发表时间:
2016-05
期刊:
Cancer immunology, immunotherapy : CII
影响因子:
--
作者:
Coleman HN;Greenfield WW;Stratton SL;Vaughn R;Kieber A;Moerman-Herzog AM;Spencer HJ;Hitt WC;Quick CM;Hutchins LF;Mackintosh SG;Edmondson RD;Erickson SW;Nakagawa M
通讯作者:
Nakagawa M
影响因子:
5.5
作者:
Wang, Xuelian;Coleman, Hannah N.;Nagarajan, Uma;Spencer, Horace J.;Nakagawa, Mayumi
通讯作者:
Nakagawa, Mayumi
DOI:
10.1111/igc.0b013e3181a388c4
发表时间:
2009-05
期刊:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
影响因子:
--
作者:
Farhat S;Nakagawa M;Moscicki AB
通讯作者:
Moscicki AB
影响因子:
0.5
作者:
Denny, Lynette
通讯作者:
Denny, Lynette